There is an urgent need to individualize radiation therapy for patients to improve outcomes and quality of life. The Kamran lab focuses on the application of computational genomic approaches to characterize tumor evolution to treatment, understand mechanisms of radiotoxicity and radioresistance, and explore the radiation-antitumor immunity interaction. In addition, we are interested in dissecting translational science in diverse populations, something that is imperative to the field of oncology. It is essential that these populations are not left behind in the field of translational genomics.
December 14, 2021: Dr. Kamran the PCF Young Investigator Award
December 9, 2021: December 9, 2021: Paper published in JAMA Oncology – Read about increasing diversity in Oncology here.
December 1, 2021: All abstracts has been accepted to GU ASCO!
November 8, 2021: Representation in clinical studies is vital! Check out our new paper about Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies in the JAMA Network.
November 3, 2021: Read about Solving the Stereotactic Body Radiotherapy and Checkpoint Inhibitor Puzzle in Metastatic Renal Cell Carcinoma in European Oncology
October 26, 2021: Dr. Kamran receives her first grant from the Prostate Cancer Foundation for TCR sequencing of oligometastatic prostate cancer
October 12, 2021: GU ASCO 2022 abstracts submitted!
October 5, 2021: Characterization of an Iodinated Rectal Spacer for Prostate Photon and Proton Radiotherapy – Paper published in Practical Radiation Oncology
July 13, 2021: Welcome to Melissa Huynh
April 1, 2021: ASCO 2021 abstracts accepted!
March 1, 2021: ASTRO abstracts submitted!
February 22, 2021: Welcome to Anushka Ghosh!
February 1, 2021: Welcome to Laura Burgess!
January 1, 2021: Welcome to Chris Aldrighetti!